1 – 100 of 102
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
-
Mark
Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients
2024) In Haemophilia(
- Contribution to journal › Article
- 2023
-
Mark
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group
(
- Contribution to journal › Scientific review
-
Mark
Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
(
- Contribution to journal › Article
- 2021
-
Mark
A comparison of MyPKFiT and WAPPS-Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa
(
- Contribution to journal › Article
-
Mark
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors : A systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
Comparison of single subject and population-based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A
(
- Contribution to journal › Article
-
Mark
Translating the success of prophylaxis in haemophilia to von Willebrand disease
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Achieving the unimaginable : Health equity in haemophilia
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Factor VIII : Long-established role in haemophilia A and emerging evidence beyond haemostasis
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram : A Nordic study
(
- Contribution to journal › Article
-
Mark
Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study
(
- Contribution to journal › Article
- 2018
-
Mark
Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B
(
- Contribution to journal › Scientific review
-
Mark
The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia
(
- Contribution to journal › Article
-
Mark
How I manage patients with inherited haemophilia A and B and factor inhibitors
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Low agreement between fresh and frozen-thawed platelet-rich plasma in the calibrated automated thrombogram assay
(
- Contribution to journal › Article
-
Mark
The importance of genetic factors for the development of arthropathy : A longitudinal study of children and adolescents with haemophilia A
(
- Contribution to journal › Article
-
Mark
The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany
(
- Contribution to journal › Article
-
Mark
Preference-based valuation of treatment attributes in haemophilia A using web survey
(
- Contribution to journal › Article
-
Mark
The impact of clinical practice on the outcome of central venous access devices in children with haemophilia
(
- Contribution to journal › Article
-
Mark
Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy : The Malmö experience
(
- Contribution to journal › Article
-
Mark
Register-based studies to assess long-term outcome in haemophilia
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Plasma-derived versus recombinant factor concentrates in PUPs : A never ending debate?
(
- Contribution to journal › Article
- 2016
-
Mark
The effect of Nordic Walking on joint status, quality of life, physical ability, exercise capacity and pain in adult persons with haemophilia
(
- Contribution to journal › Article
-
Mark
Future of haemophilia outcome assessment : Registries are key to optimized treatment
(
- Contribution to journal › Article
-
Mark
Current view and outcome of ITI therapy : A change over time?
(
- Contribution to journal › Article
-
Mark
The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands
(
- Contribution to journal › Article
-
Mark
Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe
(
- Contribution to journal › Article
-
Mark
Haemophilia treatment in 2030
(
- Contribution to journal › Article
-
Mark
SPINART study : validation of the extended magnetic resonance imaging scale for evaluation of joint status in adult patients with severe haemophilia A using baseline data
(
- Contribution to journal › Article
- 2015
-
Mark
Haemophilia in Sweden – Studies on mutations and clinical implications
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
The ageing patient with haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Co-morbidity and mortality in Swedish patients with haemophilia - A register study
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Genetic risk factors for inhibitors in haemophilia A
(
- Contribution to journal › Scientific review
-
Mark
Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand
(
- Contribution to journal › Article
-
Mark
Non-genetic risk factors and their influence on the management of patients in the clinic
(
- Contribution to journal › Scientific review
-
Mark
Interaction between VWF and FVIII in treating VWD
(
- Contribution to journal › Article
-
Mark
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies
(
- Contribution to journal › Scientific review
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
(
- Contribution to journal › Scientific review
-
Mark
Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Methods for individualising factor VIII dosing in prophylaxis
(
- Contribution to journal › Scientific review
-
Mark
Managing Haemophilia for Life: 4th Haemophilia Global Summit
(
- Contribution to journal › Scientific review
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
(
- Contribution to journal › Scientific review
-
Mark
On-demand treatment in persons with severe haemophilia
(
- Contribution to journal › Scientific review
-
Mark
Outcome measures in haemophilia: a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Perinatal aspects of haemophilia
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Health-Related Quality of Life and Adherence in Haemophilia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Progressive improvement in wound healing with increased therapy in haemophilia B mice
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
(
- Contribution to journal › Article
- 2012
-
Mark
Haemophilia Care in Europe: the ESCHQoL study
(
- Contribution to journal › Article
- 2011
-
Mark
Bone Mineral Density in Haemophilila: A Treatment Outcome
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The need for speed in the management of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Joint protection in haemophilia
(
- Contribution to journal › Article
-
Mark
Monitoring rFVIIa 90 μg kg(-1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h.
(
- Contribution to journal › Article
- 2010
-
Mark
10th anniversary of the haemophilia/haemostasis Novo Nordisk symposium
(
- Chapter in Book/Report/Conference proceeding › Preface to conference proceeding
-
Mark
FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
(
- Contribution to journal › Article
-
Mark
The role of prophylaxis in bleeding disorders
(
- Contribution to journal › Scientific review
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
(
- Contribution to journal › Article
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
(
- Contribution to journal › Scientific review
-
Mark
The plasma concentration of activated protein C appears normal in patients with haemophilia
(
- Contribution to journal › Article
-
Mark
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic
(
- Contribution to journal › Article
-
Mark
Measuring patient-reported outcomes in haemophilia clinical research
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
(
- Contribution to journal › Article
-
Mark
Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
(
- Contribution to journal › Article
-
Mark
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?
(
- Contribution to journal › Article
-
Mark
European principles of haemophilia care
(
- Contribution to journal › Article
-
Mark
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance.
(
- Contribution to journal › Scientific review
-
Mark
Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.
(
- Contribution to journal › Article
- 2007
-
Mark
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors
(
- Contribution to journal › Article
-
Mark
Prevention of bleeding in haemophilia: trends, overcoming barriers and future treatment options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
MRI assessment of haemophilic arthropathy
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
(
- Contribution to journal › Article
- 2006
-
Mark
Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors.
(
- Contribution to journal › Article
-
Mark
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
(
- Contribution to journal › Article
-
Mark
Inhibitor treatment in haemophilas A and B: Summary statement for the 2006 International Consensus Conference
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reliability and construct validity of the compatible MRI scoring system for evaluation of haemophilic knees and ankles of haemophilic children. Expert MRI working group of the international prophylaxis study group
(
- Contribution to journal › Article
-
Mark
Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia
(
- Contribution to journal › Article
-
Mark
Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.
(
- Contribution to journal › Article
-
Mark
Pharmacoeconomics of factor dosing in the haemophilia population.
(
- Contribution to journal › Article
- 2005
-
Mark
Reliability of progressive and additive MRI scoring systems for evaluation of haemophilic arthropathy in children: Expert MRI Working Group of the International Prophylaxis Study Group
(
- Contribution to journal › Article
- 2004
-
Mark
Optimizing factor prophylaxis for the haemophilia population: where do we stand?
(
- Contribution to journal › Article
-
Mark
A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia
(
- Contribution to journal › Article
-
Mark
Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
(
- Contribution to journal › Article
- 2002
-
Mark
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
(
- Contribution to journal › Article
- 2001
-
Mark
The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients
(
- Contribution to journal › Article
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
(
- Contribution to journal › Article
-
Mark
Symposium in memory of Professor Inga Marie Nilsson
(
- Contribution to journal › Published meeting abstract
- 1999
-
Mark
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized
(
- Contribution to journal › Article
-
Mark
Tolerance induction using the Malmo treatment model 1982-1995
(
- Contribution to journal › Article
-
Mark
Long-term psychological effects of carrier testing and prenatal diagnosis of haemophilia: Comparison with a control group
(
- Contribution to journal › Article
-
Mark
Reproductive choices of haemophilia carriers
(
- Contribution to journal › Article
-
Mark
Prenatal Diagnosis of Haemophilia - psychological, social and ethical aspects
1999)(
- Thesis › Doctoral thesis (compilation)
- 1998
-
Mark
Major surgery seems not to influence HIV disease progression in haemophilia patients
(
- Contribution to journal › Article
-
Mark
Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995
(
- Contribution to journal › Article
-
Mark
The Malmo-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts
(
- Contribution to journal › Scientific review
-
Mark
Extracorporeal immunoadsorption
1998)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Carrier testing and prenatal diagnosis of haemophilia - utilisation and psychological consequences
(
- Contribution to journal › Article
- 1995
-
Mark
Inversions of the factor VIII gene in Swedish patients with severe haemophilia A
(
- Contribution to journal › Article